84 results
8-K
EX-1.1
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
) Each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), for which … , officer or employee of the Company or any of its subsidiaries, or any agent, affiliate or other person associated with or acting on behalf of the Company
424B5
NRIX
Nurix Therapeutics Inc
12 Apr 24
Prospectus supplement for primary offering
5:10pm
of our common stock granted after February 29, 2024) and (ii) 1,843,908 shares of common stock reserved for future issuance under the 2020 Employee … equityholders of the lock-up party; (vii) by operation of law, (viii) to us, (A) from an employee or other service provider upon death, disability
424B5
NRIX
Nurix Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:06pm
stock granted after February 29, 2024) and (ii) 1,843,908 shares of common stock reserved for future issuance under the 2020 Employee Stock Purchase … of a distribution to stockholders, partners, members or other equityholders of the lock-up party; (vii) by operation of law, (viii) to us, (A) from an employee
S-8
cto8dlid1 6ao0p
15 Feb 24
Registration of securities for employees
4:51pm
S-8
s5yagemq97hptxdn1a
15 Feb 24
Registration of securities for employees
4:51pm
S-8
EX-5.1
dr9rib
15 Feb 24
Registration of securities for employees
4:51pm
8-K
EX-3.1
3u48flkx hgyfb9
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
z5chtlr01
14 Sep 22
Nurix Therapeutics Appoints Leading Industry Strategist Edward C. Saltzman to its Board of Directors
4:01pm
8-K
EX-10.1
kp4ael
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
424B5
pqmika9 1mltj6l
8 Jul 22
Prospectus supplement for primary offering
4:10pm
424B5
6341d
8 Jul 22
Prospectus supplement for primary offering
4:09pm